These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 3027158)

  • 1. [Uterine cervix dysplasias. New therapeutic strategy based on virological data].
    Parent B; Huynh B
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(7):941-7. PubMed ID: 3027158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
    Harper DM
    Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low prevalence of human papillomavirus types 16 and 18 in cervical adenocarcinoma in situ, invasive adenocarcinoma, and glandular dysplasia by polymerase chain reaction.
    Lee KR; Howard P; Heintz NH; Collins CC
    Mod Pathol; 1993 Jul; 6(4):433-7. PubMed ID: 8415587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frequency of HPV infection and level of glutathione in serum of women with cervix dysplasia].
    Kwaśniewska A; Tukendorf A; Semczuk M
    Med Dosw Mikrobiol; 1995; 47(3-4):213-8. PubMed ID: 8833934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cervical condyloma and dysplasia: histological and virological correlation apropos of 100 cases].
    Guillet G; Braun L; Shah K; Ferenczy A
    Ann Dermatol Venereol; 1983; 110(1):43-51. PubMed ID: 6305251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
    Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
    Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract.
    Vinokurova S; Wentzensen N; Einenkel J; Klaes R; Ziegert C; Melsheimer P; Sartor H; Horn LC; Höckel M; von Knebel Doeberitz M
    J Natl Cancer Inst; 2005 Dec; 97(24):1816-21. PubMed ID: 16368943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Typing of human papillomaviruses in intra-epithelial malpighian lesions of the cervix uteri: correlation with cytohistologic grade and progression of the lesions].
    Daste G; Butet MH; Berrebi A; Viraben R; Henry S; Soleilhavoup JP
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(1):28-34. PubMed ID: 8157887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus type specific DNA and RNA persistence--implications for cervical disease progression and monitoring.
    Cuschieri KS; Whitley MJ; Cubie HA
    J Med Virol; 2004 May; 73(1):65-70. PubMed ID: 15042650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of HPV infection in CIN and invasive cancers by in situ hybridization method--comparison with histopathology].
    Ishi K; Saito A; Kina K; Kawashima T; Utsuno H; Nakamura H; Igari J
    Rinsho Byori; 1993 Oct; 41(10):1167-72. PubMed ID: 8254963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlations between the HPV type, DNA index and evolution of cervical intraepithelial neoplasia (CIN)].
    Sassi I; Mangili F; Luchini S; Colombo G; Pezzotta MG; Candiani M; Frigerio A; Santambrogio G; Cantaboni A; Vignali M
    Pathologica; 1993; 85(1095):79-84. PubMed ID: 8390639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
    Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
    Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus typing in patients with Papanicolaou smears showing squamous atypia.
    Goff BA; Muntz HG; Bell DA; Wertheim I; Rice LW
    Gynecol Oncol; 1993 Mar; 48(3):384-8. PubMed ID: 8385061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical dysplasia: early intervention.
    Marshall K
    Altern Med Rev; 2003 May; 8(2):156-70. PubMed ID: 12777161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus vaccine for genotypes 6, 11, 16 and 18: new drug. Cervical cancer prevention: high hopes...
    Prescrire Int; 2007 Jun; 16(89):91-4. PubMed ID: 17582921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study on the relationship between cervical carcinoma, dysplasia and sexually transmitted diseases].
    Hu W; Gu M
    Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):547-9. PubMed ID: 8556916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology.
    Bollen LJ; Tjong-A-Hung SP; van der Velden J; Mol BW; ten Kate FW; ter Schegget J; Bleker OP
    Gynecol Oncol; 1999 Feb; 72(2):199-201. PubMed ID: 10021301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical squamous dysplasias and carcinomas with immunodetectable p53 frequently contain HPV.
    Mittal KR; Lin O; Chan W; Goswami S; Demopoulos RI
    Gynecol Oncol; 1995 Sep; 58(3):289-94. PubMed ID: 7672694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of the most common high-risk HPV genotypes among women in three new independent states of the former Soviet Union.
    Kulmala SM; Shabalova IP; Petrovitchev N; Syrjänen KJ; Gyllensten UB; Syrjänen SM;
    J Med Virol; 2007 Jun; 79(6):771-81. PubMed ID: 17457909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [May ureaplasmas in genital tract of HPV-positive women influence abnormal cytology of cervix?].
    Biernat-Sudolska M; Szostek S; Rojek-Zakrzewska D; Kopeć J; Zawilińska B
    Przegl Epidemiol; 2008; 62(2):447-52. PubMed ID: 18807493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.